Id |
Subject |
Object |
Predicate |
Lexical cue |
T162 |
12-19 |
CHEBI:59132;CHEBI:59132 |
denotes |
pneumo |
T163 |
43-59 |
CHEBI:35705;CHEBI:35705 |
denotes |
immunomodulatory |
T69247 |
58-73 |
CHEBI:35705;CHEBI:35705 |
denotes |
y drugs such as |
T164 |
60-65 |
CHEBI:23888;CHEBI:23888 |
denotes |
drugs |
T20303 |
74-79 |
CHEBI:23888;CHEBI:23888 |
denotes |
anaki |
T165 |
96-111 |
PR:000001137 |
denotes |
interleukin-1Ra |
T81754 |
110-116 |
PR:000001137 |
denotes |
a), to |
T166 |
114-125 |
DG_35 |
denotes |
tocilizumab |
T16643 |
119-130 |
DG_35 |
denotes |
izumab (ant |
T167 |
132-145 |
PR:000001393 |
denotes |
interleukin-6 |
T55627 |
137-140 |
PR:000001393 |
denotes |
leu |
T168 |
164-174 |
CHEBI:35222;CHEBI:35222 |
denotes |
inhibitors |
T41646 |
165-175 |
CHEBI:35222;CHEBI:35222 |
denotes |
nhibitors, |
T169 |
208-216 |
SP_7 |
denotes |
COVID-19 |
T67111 |
209-216 |
SP_7 |
denotes |
OVID-19 |